Deferred Tax Assets, Valuation Allowance of Alzamend Neuro, Inc. from 30 Apr 2020 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Alzamend Neuro, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Apr 2020 to 30 Apr 2025.
  • Alzamend Neuro, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Apr 2025 was $15,247,397, a 3.3% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $15,247,397 -$519,407 -3.3% 30 Apr 2025 10-K 22 Jul 2025 2025 FY
Q1 2024 $15,766,804 +$4,953,755 +46% 30 Apr 2024 10-K 22 Jul 2025 2025 FY
Q1 2023 $10,813,049 +$736,118 +7.3% 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q1 2022 $10,076,931 +$5,722,286 +131% 30 Apr 2022 10-K 27 Jul 2023 2023 FY
Q1 2021 $4,354,645 +$1,510,351 +53% 30 Apr 2021 10-K 19 Jul 2022 2022 FY
Q1 2020 $2,844,294 30 Apr 2020 10-K 29 Jul 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.